For the Initial Treatment of Venous Thromboembolism: Are All Low-molecular-weight Heparin Compounds the Same?
- 15 October 2000
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 100 (2) , 121-130
- https://doi.org/10.1016/s0049-3848(00)00272-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Heparin and Low-Molecular-Weight HeparinChest, 1998
- The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrenceArchives of internal medicine (1960), 1997
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Diagnosis of Heparin-induced Thrombocytopenia:Still a Journey, Not Yet a DestinationAmerican Journal of Clinical Pathology, 1995
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Acenocoumarol and Heparin Compared with Acenocoumarol Alone in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1992
- HeparinNew England Journal of Medicine, 1991
- Heparin for 5 Days as Compared with 10 Days in the Initial Treatment of Proximal Venous ThrombosisNew England Journal of Medicine, 1990
- Different Intensities of Oral Anticoagulant Therapy in the Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1982
- ANTICOAGULANT DRUGS IN THE TREATMENT OF PULMONARY EMBOLISMThe Lancet, 1960